Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,809 | 120,779 | -32,885 | -22,349 | -24,478 |
| Depreciation Amortization | 1,753 | 4,070 | 2,187 | 932 | 2,142 |
| Income taxes - deferred | -38 | -38,760 | 1,602 | N/A | N/A |
| Accounts receivable | -4,263 | -3,390 | -988 | -1,642 | -416 |
| Accounts payable and accrued liabilities | -360 | -10,375 | -5,502 | -7,326 | 1,363 |
| Other Working Capital | -11,263 | -15,435 | -4,479 | -12,123 | 1,648 |
| Other Operating Activity | 8,817 | -89,008 | 26,943 | 15,197 | 3,192 |
| Operating Cash Flow | $-7,163 | $-32,119 | $-13,122 | $-27,311 | $-16,549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,658 | -5,350 | -1,295 | -856 | -3,391 |
| Net Acquisitions | N/A | N/A | N/A | -27,515 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -43 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 269 |
| Investing Cash Flow | $-1,658 | $-5,350 | $-1,295 | $-28,371 | $-3,122 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 29,457 | N/A |
| Debt Repayment | N/A | -60 | N/A | N/A | -122 |
| Common Stock Issued | 4,035 | 3,241 | 39,859 | 76 | 53,783 |
| Common Stock Repurchased | -6,992 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -224 | -32,488 | -473 | -419 | 0 |
| Financing Cash Flow | $-3,181 | $-29,307 | $39,386 | $29,114 | $53,661 |
| Exchange Rate Effect | 428 | -1,711 | 451 | -1,780 | -440 |
| Beginning Cash Position | 192,944 | 90,532 | 59,310 | 83,795 | 50,165 |
| End Cash Position | 181,370 | 192,944 | 90,532 | 59,310 | 83,715 |
| Net Cash Flow | $-11,574 | $102,412 | $31,222 | $-24,485 | $33,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,163 | -32,119 | -13,122 | -27,311 | -16,549 |
| Capital Expenditure | -1,658 | -5,350 | -1,295 | -856 | -3,425 |
| Free Cash Flow | -8,821 | -37,469 | -14,417 | -28,167 | -19,974 |